undamentalytics Newsletter

Stanger Kent W: insider trades

Chief financial officer, Director at Merit Medical Systems Inc. No open-market purchases and 15 sales not made under a pre-set plan, reported from February 11, 2011 to April 2, 2019.

What happened after Stanger Kent W’s sales?

After their sales, the shares moved +21.8% against the index over 12 months on average (a negative figure means selling was the right call); 13% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Stanger Kent W: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 15 −2.5% −4.5% 67% 5 0.44 0.68 No reliable evidence
Sales, 12 months after the report 15 +21.8% +31.7% 13% 5 0.89 0.42 No reliable evidence
Sales, 12 months after the trade 15 +22.0% +32.2% 13% 5 1.11 0.33 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Merit Medical Systems Inc MMSI Chief Financial Officer015February 11, 2011April 2, 2019

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
April 2, 2019March 29, 2019 MMSI Sale $746,519 −7.9%−39.0%−44.5%
March 28, 2019March 26, 2019 MMSI Sale $301,691 −7.9%−44.5%−34.9%
December 19, 2017December 15, 2017 MMSI Sale $407,782 +2.4%+25.1%+22.3%
December 1, 2017November 29, 2017 MMSI Sale $130,006 +1.9%+36.6%+34.7%
September 18, 2017September 14, 2017 MMSI Sale $28,180 +0.2%+30.0%+30.8%
September 13, 2017September 11, 2017 MMSI Sale $81,099 −3.9%+30.8%+27.4%
August 9, 2017August 7, 2017 MMSI Sale $312,409 −12.6%+19.2%+12.8%
December 12, 2016December 8, 2016 MMSI Sale $315,280 +11.2%+47.2%+46.2%
March 8, 2016March 4, 2016 MMSI Sale $96,700 −1.5%+39.3%+36.1%
March 3, 2016March 1, 2016 MMSI Sale $377,900 −4.5%+36.1%+40.6%
June 9, 2014June 5, 2014 MMSI Sale $312,397 −15.4%+36.9%+38.4%
June 3, 2014May 30, 2014 MMSI Sale $81,179 −15.3%+37.5%+35.9%
May 29, 2014May 27, 2014 MMSI Sale $225,178 −16.4%+35.9%+32.2%
May 22, 2014May 20, 2014 MMSI Sale $311,627 −18.0%+31.7%+34.3%
February 11, 2011February 4, 2011 MMSI Sale $232,337 +50.6%+4.4%+18.1%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Stanger Kent W traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.